Stress ulcer prophylaxis in the cardiac surgery intensive care unit
- PMID: 35274134
- PMCID: PMC9334784
- DOI: 10.1093/ejcts/ezac177
Stress ulcer prophylaxis in the cardiac surgery intensive care unit
Comment on
-
Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac124. doi: 10.1093/ejcts/ezac124. Eur J Cardiothorac Surg. 2022. PMID: 35213716 Free PMC article. Clinical Trial.
References
-
- Young PJ, Bagshaw SM, Forbes AB, Nichol AD, Wright SE, Bailey M. et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA 2020;323:616–26. - PMC - PubMed
-
- https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000... (22 February 2022, date last accessed).
-
- Young PJ, Bagshaw SM, Forbes A, Nichol A, Wright SE, Bellomo R. et al. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. Crit Care Resusc 2018;20:182–9. - PubMed